Skip to main content
Equibles

AMBIQ · Ambipar Emergency Response · Financials

Track AMBIQ — free

Use AMBIQ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMBIQ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.07 +0.07 (+69,900.00%) At close · Oct 2
Rebalance outlook locked
Market Cap
$3.88M
Shares
55.43M
Volume · Oct 2 15.71K Avg daily vol (6 sessions) 8171

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
3.25B +25.4%
FY2024 Revenue FY2020–FY2024
Net Income
-20.56M +67.1%
FY2024 Net Income FY2020–FY2024
Gross Margin
14.74% -4.6pp
FY2024 Gross Margin FY2020–FY2024
Operating Margin
14.95% +1pp
FY2024 Operating Margin FY2020–FY2024
Operating Cash Flow
421.37M +436.9%
FY2024 Operating Cash Flow FY2020–FY2024

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2024 FY2023 FY2022 FY2021 FY2020
BRL 3.25B 2.59B 1.68B 822.2M 364.28M
BRL 2.77B 2.09B 1.34B 618.69M 256.15M
BRL 478.78M 499.48M 347.15M 203.51M 108.14M
BRL 322.51M 181.86M 112.03M 60.16M 22.52M
BRL 485.77M 360.38M 336.76M 178.03M 89.89M
BRL 592.9M 294.83M 113.54M 12.8M 14.48M
BRL 126.78M 109.04M 232.79M 176M 82.81M
BRL -68.02M -91.87M -44.91M -37.86M 16.75M
BRL -20.56M -62.48M 161.49M 131.12M 61.7M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2024: 83.72M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Borrowings 2024-12-31 BRL 1,454,039,000 20-F filed 2025-06-24
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current borrowings, including current portion of noncurrent borrowings
BRL 212,105,000
Current portion of long-term borrowings
BRL 198,906,000
Noncurrent long-term borrowings
BRL 778,039,000
Current notes and debentures issued, including current portion of noncurrent notes and debentures 2024-12-31 BRL 84,072,000 20-F filed 2025-06-24
Lease liabilities 2024-12-31 BRL 304,097,000 20-F filed 2025-06-24
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
BRL 64,357,000
Noncurrent lease liabilities
BRL 239,740,000
Noncurrent notes and debentures issued 2024-12-31 BRL 379,823,000 20-F filed 2025-06-24
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1937441 Visit website Investor relations